Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCQ pretreatment in advanced nasopharyngeal carcinoma
NCT06389201Phase 2Recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Aug 2024
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in nasopharyngeal carcinoma (NPC), sponsored by Affiliated Hospital of Nantong University. Started Aug 2024; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT06389201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06389201.